Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
13:50 | Bullion Gold Resources Corporation: Bullion Gold Expands the Lac Rivon West Copper System, Tichegami - Eeyou Istchee Baie-James | 265 | Newsfile | Montreal, Quebec--(Newsfile Corp. - August 14, 2025) - Bullion Gold Resources (TSXV: BGD) ("Bullion Gold" or the "Company") announces the completion of a field prospecting program on its wholly owned... ► Artikel lesen | |
Mi | Bullion Gold Resources Corp (2): Bullion drilling shows shallow gold over 200 m strike | 1 | Stockwatch | ||
Mi | Bullion Gold Resources Corporation: Drilling at Amadee Prospect Confirms Shallow Gold Mineralisation | 406 | Newsfile | Montreal, Quebec--(Newsfile Corp. - August 12, 2025) - Bullion Gold Resources (TSXV: BGD) ("Bullion Gold" or the "Company") and its partner Olympio Metals Limited are pleased to announce that results... ► Artikel lesen | |
05.08. | Bullion Gold Resources Corporation: Further High-Grade Gold Intersections at Bousquet | 319 | Newsfile | Montreal, Quebec--(Newsfile Corp. - August 5, 2025) - Bullion Gold Resources Corp. (TSXV: BGD) ("Bullion Gold" or the "Company") and its partner Olympio Metals Limited are pleased to announce that... ► Artikel lesen | |
BULLION GOLD RESOURCES Aktie jetzt für 0€ handeln | |||||
29.07. | Bullion Gold Resources Corp (2): Bullion partner drills 7.9 m of 6.2 g/t Au at Bousquet | 2 | Stockwatch | ||
28.07. | Bullion Gold Resources Corporation: High-Grade Gold up to 42.3 g/t Confirmed in First Two Drillholes at Bousquet | 285 | Newsfile | Montreal, Quebec--(Newsfile Corp. - July 28, 2025) - Bullion Gold Resources Corp. (TSXV: BGD) ("Bullion Gold" or the "Company") announces that its Australian partner Olympio Metals has successfully... ► Artikel lesen | |
10.07. | Bullion Gold Resources Corp (2): Bullion Gold private placement | 1 | Stockwatch | ||
10.07. | Bullion Gold Resources Corp (2): Bullion's Bousquet optionee Olympio continues drilling | 1 | Stockwatch | ||
09.07. | Bullion Gold Resources Corporation: Bullion Gold Reports Olympio Metals Continues Drilling Program on Bousquet Beyond the Initial Planned Program | 288 | Newsfile | Montreal, Quebec--(Newsfile Corp. - July 9, 2025) - Bullion Gold Resources Corp. (TSXV: BGD) ("Bullion Gold" or the "Company") announces that its Australian partner Olympio Metals is continuing its... ► Artikel lesen | |
04.07. | Bullion Gold Resources Corp (2): Bullion Gold shareholders OK all resolutions at AGM | 4 | Stockwatch | ||
04.07. | Bullion Gold Resources Corporation: Bullion Gold Announces Results of Annual General Meeting | 572 | Newsfile | Montreal, Quebec--(Newsfile Corp. - July 3, 2025) - Bullion Gold Resources Corp. (TSXV: BGD) ("Bullion Gold" or "the Company") is pleased to announce that shareholders have approved of all resolutions... ► Artikel lesen | |
03.07. | Bullion Gold Resources Corp (2): Bullion Gold's Bousquet intersects visible gold | 1 | Stockwatch | ||
02.07. | Bullion Gold Resources Corporation: Exploration Work Advances on Bousquet, Bodo, and Langlade Projects | 414 | Newsfile | Montreal, Quebec--(Newsfile Corp. - July 2, 2025) - Bullion Gold Resources (TSXV: BGD) ("Bullion Gold" or "The Company") is pleased to provide an update to its shareholders and the public regarding... ► Artikel lesen | |
21.06. | Bullion Gold Resources Corp (2): Bullion Gold acquisition of Cadillac extension project | 2 | Stockwatch | ||
19.06. | Bullion Gold Resources Corp (2): Bullion Gold closes Cadillac Extension acquisition | 1 | Stockwatch | ||
18.06. | Bullion Gold Resources Corporation: Bullion Gold Completes the Acquisition of the Cadillac Extension (Langlade) Project | 477 | Newsfile | Montreal, Quebec--(Newsfile Corp. - June 18, 2025) - Bullion Gold Resources Corp. (TSXV: BGD) ("Bullion Gold" or the "Company") is pleased to announce that it has closed the transaction to acquire... ► Artikel lesen | |
05.06. | Bullion Gold Resources Corp (2): Bullion Gold Resources private placement | 1 | Stockwatch | ||
05.06. | Bullion Gold Resources Corp (2): Bullion Gold private placement | 1 | Stockwatch | ||
03.06. | Bullion Gold Resources Corporation: Bullion Gold Begins Exploration Work on Bodo | 676 | Newsfile | Montreal, Quebec--(Newsfile Corp. - June 3, 2025) - Bullion Gold Resources Corp. (TSXV: BGD) ("Bullion Gold" or the "Company") is pleased to announce the imminent launch of a second exploration program... ► Artikel lesen | |
09.05. | Bullion Gold Resources Corp (2): Bullion Gold signs LOI for Cadillac Extension project | 1 | Stockwatch |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
QIAGEN | 41,975 | -0,33 % | JEFFERIES stuft QIAGEN NV auf 'Buy' | NEW YORK (dpa-AFX Analyser) - Das Analysehaus Jefferies hat das Kursziel für Qiagen nach Zahlen von 54 auf 57 US-Dollar angehoben und die Einstufung auf "Buy" belassen. Tycho Peterson attestierte dem... ► Artikel lesen | |
EVOTEC | 6,548 | +1,84 % | BASF Aktie: Rallye voraus? - Bayer, CLIQ Digital, Commerzbank, Evotec und Kontron im Marktbericht Börse Frankfurt | Wo ist am Aktienmarkt etwas los, welche Themen interessieren Anleger derzeit besonders? Vor allem für Trader ist es wichtig zu wissen, wo "die Musik spielt" und welche Themen an der Börse aktuell besonders... ► Artikel lesen | |
VALNEVA | 4,372 | -6,58 % | Valneva: FDA gibt Chikungunya-Impfstoff IXCHIQ wieder frei | Valneva hat bekanntgegeben, dass die US-Arzneimittelbehörde FDA die zuvor empfohlene Einschränkung für den Chikungunya-Impfstoff IXCHIQ bei Personen ab 60 Jahren aufgehoben hat. Zugleich wurde eine... ► Artikel lesen | |
TRINITY BIOTECH | 2,920 | +189,11 % | Trinity Biotech plc: Trinity Biotech Receives Regulatory Approval to Begin FDA-Cleared PreClara Preeclampsia Testing Service | DUBLIN, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable... ► Artikel lesen | |
BIONTECH | 96,05 | -0,41 % | Neues Zoll Drama - wie Novo Nordisk, Vidac Pharma und BioNTech mit KI und Onkologie dem Protektionismus begegnen | Die globale Pharmabranche erlebt 2025 eine historische Doppelrevolution: Künstliche Intelligenz beschleunigt Forschung und personalisierte Therapien, während disruptive US-Zölle von bis zu 250 % Lieferketten... ► Artikel lesen | |
RECURSION PHARMACEUTICALS | 5,570 | -2,28 % | Recursion Pharmaceuticals: Recursion Reports Second Quarter 2025 Financial Results and Provides Business Update | SALT LAKE CITY, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Recursion (Nasdaq: RXRX) a leading clinical stage TechBio company decoding biology to radically improve lives, today reported business updates and... ► Artikel lesen | |
BEAM THERAPEUTICS | 17,730 | +1,20 % | Beam Therapeutics Announces U.S. FDA Regenerative Medicine Advanced Therapy (RMAT) Designation Granted to BEAM-101 for the Treatment of Sickle Cell Disease | CAMBRIDGE, Mass., Aug. 14, 2025 (GLOBE NEWSWIRE) -- Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, today announced that... ► Artikel lesen | |
180 LIFE SCIENCES | 7,260 | -32,50 % | 180 Life Sciences setzt auf Ethereum - Milliardenwechsel in Geschäftsstrategie | Die 180 Life Sciences Corp. (Börsenkürzel: ATNF) hat bekanntgegeben, inzwischen 82.186 Ether-Token zu halten - ein Bestand, der zum 11. August 2025 rund 349 Millionen US-Dollar wert war. Der durchschnittliche... ► Artikel lesen | |
MODERNA | 22,515 | -2,02 % | Moderna-Aktie heute gut behauptet: Aktienwert steigt (22,935 €) | Das Wertpapier von Moderna notiert am Mittwoch etwas fester. Das Wertpapier notiert gegenwärtig bei 22,94 Euro. Für das Wertpapier von Moderna steht gegenwärtig ein Wertanstieg 4,37 Prozent zu Buche.... ► Artikel lesen | |
ARS PHARMACEUTICALS | 14,920 | -5,57 % | ARS Pharmaceuticals stock maintains Strong Buy rating at Raymond James on strong neffy sales | ||
SAREPTA THERAPEUTICS | 17,435 | 0,00 % | Sarepta Sells Arrowhead Stake to Fund Milestone Payment | ||
AVIDITY BIOSCIENCES | 45,770 | -0,82 % | Avidity Biosciences, Inc.: Avidity Biosciences Reports Second Quarter 2025 Financial Results and Recent Highlights | Aligned with FDA on del-brax accelerated and full approval pathways for FSHD, reported positive topline data from Phase 1/2 FORTITUDE trial, and initiated global... ► Artikel lesen | |
SUMMIT THERAPEUTICS | 27,005 | +0,61 % | Summit Therapeutics: Ivonescimab Data from Global Phase III HARMONi Study to be Showcased at Presidential Symposium at WCLC 2025 | Ivonescimab to be Featured at WCLC Presidential Symposium for Second Consecutive Year
Summit Therapeutics Inc. (NASDAQ: SMMT) ("Summit," "we," or the "Company") today announced that data from the... ► Artikel lesen | |
RAPPORT THERAPEUTICS | 15,600 | 0,00 % | Rapport Therapeutics, Inc. - 10-Q, Quarterly Report | ||
STRYKER | 323,20 | -0,22 % | Former Stryker president joins Longevity Neuro as board chair |